Nurr1 in Parkinson's disease and related disorders

Journal of Comparative Neurology

Volumn 494, Issue 3, 2006, Pages 495-514

  Chu, Yaping ^a   Le, Weidong ^b   Kompoliti, Katie ^a   Jankovic, Joseph ^b   Mufson, Elliott J ^a   Kordower, Jeffrey H ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

synuclein; Dopaminergic neuron; Neurofilament; Substantia nigra; Transcription factor

Indexed keywords

ALPHA SYNUCLEIN; NUCLEAR RECEPTOR RELATED FACTOR 1;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MALE; NEUROFIBRILLARY TANGLE; NIGRONEOSTRIATAL SYSTEM; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN EXPRESSION; SUBSTANTIA NIGRA; SYNUCLEINOPATHY; TAUOPATHY;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; CELL COUNT; DNA-BINDING PROTEINS; DOPAMINE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; NEUROFIBRILLARY TANGLES; NEURONS; PARKINSON DISEASE; REFERENCE VALUES; SUBSTANTIA NIGRA; SUPRANUCLEAR PALSY, PROGRESSIVE; TISSUE DISTRIBUTION; TRANSCRIPTION FACTORS; TYROSINE 3-MONOOXYGENASE;

EID: 29044442613     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.20828     Document Type: Article

References (37)

1. Baptista MJ, O'Farrell C, Daya S, Ahmad R, Miller DW, Hardy J, Farrer MJ, Cookson MR. 2003. Co-ordinate transcriptional regulation of dopamine synthesis genes by alpha-synuclein in human neuroblastoma cell lines. J Neurochem 85:957-968.
2. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. 2003. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24:197-211.
3. Castillo SO, Baffi JS, Palkovits M, Goldstein DS, Kopin IJ, Witta J, Magnuson MA, Nikodem VM. 1998. Dopamine biosynthesis is selectively abolished in SN/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurr1 gene. Mol Cell Neurosci 1:36-46.
4. Cavalieri B. 1966. Geometri degli indivisibli. Tornio: Undone Tipografico. p 1-543.
5. Chiang MF, Liu WK, Yen SH. 1993. Reversible heat stress-related loss of phosphorylated Alzheimer-type epitopes in Tau proteins of human neuroblastoma cells. J Neurosci 11:4854-4860.
6. Chu Y, Cochran EJ, Bennett DA, Mufson EJ, Kordower JH. 2001. Down-regulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease. J Comp Neurol 437:296-307.
7. Chu Y, Kompoliti K, Cochran EJ, Mufson EJ, Kordower JH. 2002. Age-related decreases in Nurr1 immunoreactivity in the human SN, J Comp Neurol 450:203-214.
8. Constantino AE, Honig LS. 2001. Parkinson's disease. Sci Aging Knowledge Environ 7:dn4.
9. Dawson TM, Dawson VL. 2003. Molecular pathways of neurodegeneration in Parkinson's disease [Review]. Science 302:819-822.
10. Eells JB. 2003. The control of dopamine neuron development, function and survival: insights from transgenic mice and the relevance to human disease [Review]. Curr Med Chem 10:857-870.
11. Eells JB, Lipska BK, Yeung SK, Misler JA, Nikodem VM. 2002. Nurr1-null heterozygous mice have reduced mesolimbic and mesocortical dopamine levels and increased stress-induced locomotor activity. Behav Brain Res 136:267-275.
12. Goldberg MS, Lansbury PT Jr. 2000. A cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease? Nat Cell Biol 2:E115-119.
13. Gundersen HJ, Jensen EB. 1987. The efficiency of systematic sampling in stereology and its prediction. J Microsc 147:229-263.
14. Hermanson E, Joseph B, Castro D, Lindqvist E, Aarnisalo P, Wallen A, Benoit G, Hengerer B, Olson L, Perlmann T. 2003. Nurr1 regulates dopamine synthesis and storage in MN9D dopamine cells. Exp Cell Res 288:324-334.
15. Jakes R, Crowther RA, Lee VM, Trojanowski JQ, Iwatsubo T, Goedert M. 1999. Epitope mapping of LB509, a monoclonal antibody directed against human alpha-synuclein. Neurosci Lett 269:13-16.
16. Kastner A, Hirsch EC, Herrero MT, Javoy-Agid F, Agid Y. 1993. Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease. J Neurochem 61:1024-1034.
17. Kim JH, Auerbach JM, Rodriguez-Gomez JA, Velasco I, Gavin D, Lumelsky N, Lee SH, Nguyen J, Sanchez-Pernaute R, Bankiewicz K, McKay R. 2002. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418:50-456.
18. Kim KS, Kim CH, Hwang DY, Seo H, Chung S, Hong SJ, Lim JK, Anderson T, Isacson O. 2003. Orphan nuclear receptor Nurr1 directly transactivates the promoter activity of the tyrosine hydroxylase gene in a cell-specific manner. J Neurochem 85:622-634.
19. Kitahama K, Geffard M, Okamura H, Nagatsu I, Mons N, Jouvet M. 1990. Dopamine- and dopa-immunoreactive neurons in the cat forebrain with reference to tyrosine hydroxylase-immunohistochemistry. Brain Res 518:83-94
20. Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L, McBride J, Chen EY, Palfi S, Roitberg BZ, Brown WD, Holden JE, Pyzalski R, Taylor MD, Carvey P, Ling Z, Trono D, Hantraye P, Deglon N, Aebischer P. 2000. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290:767-773.
21. Kordower JH, Chu Y, Stebbins GT, DeKosky ST, Cochran EJ, Bennett D, Mufson EJ. 2001. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol 49:202-213.
22. Le W, Conneely OM, He Y, Jankovic J, Appel SH. 1999. Reduced Nurr1 expression increases the vulnerability of mesencephalic dopamine neurons to MPTP-induced injury. J Neurochem 73:2218-2221.
23. Luo Y, Henricksen LA, Maguire-zeiss KA, Federoff HJ. 2003. Development of Nurr1 stable cell lines for the identification of downstream targets. Ann N Y Acad Sci 991:354-358.
24. Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L. 2000. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287:1265-1269.
25. Michotte A. 2003. Recent developments in the neuropathological diagnosis of Parkinson's disease and parkinsonism [Review]. Acta Neurol Belg 103:155-158.
26. Ross GW, Petrovitch H, Abbott RD, Nelson J, Markesbery W, Davis D, Hardman J, Launer L, Masaki K, Tanner CM, White LR. 2004. Parkinsonian signs and substantia nigra neuron density in decendents elders without PD. Ann Neurol 56:532-539.
27. Sacchetti P, Mitchell TR, Granneman JG, Bannon MJ. 2001. Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism. J Neurochem 76:1565-1572.
28. Sampathu DM, Giasson BI, Pawlyk AC, Trojanowski JQ, Lee VM-Y. 2003. Ubiquitination of α-synuclein is not required for formation of pathological inclusions in α-synucleinopathies. Am J Pathol 163:91-100
29. Saucedo-Cardenas O, Quintana-Hau JD, Le WD, Smidt MP, Cox JJ, De Mayo F, Burbach JP, Conneely OM. 1998. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc Natl Acad Sci U S A 95:4013-4018.
30. Schmitz C, Hof PR. 2000. Recommendations for straightforward and rigorous methods of counting neurons based on a computer simulation approach. J Chem Neuroanat 20:93-114.
31. Simon HH, Bhatt L, Gherbassi D, Sgado P, Alberi L. 2003. Midbrain dopaminergic neurons: determination of their developmental fate by transcription factors. Ann N Y Acad Sci 991:36-47.
32. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. 1997. Alpha-synuclein in Lewy bodies. Nature 388:839-840.
33. Vernier P, Moret F, Callier S, Snapyan M, Wersinger C, Sidhu A. 2004. The degeneration of dopamine neurons in Parkinson's disease: insights from embryology and evolution of the mesostriatocortical system. Ann N Y Acad Sci 1035:231-249.
34. Wallen AA, Castro DS, Zetterstrom RH, Karlen M, Olson L, Ericson J, Perlmann T. 2001. Orphan nuclear receptor Nurr1 is essential for Ret expression in midbrain dopamine neurons and in the brain stem. Mol Cell Neurosci 18:649-663.
35. West MJ, Slomianka L, Gundersen HJ. 1991. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 231:482-497.
36. Zetterstrom RH, Solomin L, Jansson L, Hoffer BJ, Olson L, Perlmann T. 1997. Dopamine neuron agenesis in Nurr1-deficient mice. Science 276:248-250.
37. Zhu MY, Klimek V, Dilley GE, Haycock JW, Stockmeier C, Overholser JC, Meltzer HY, Ordway GA. 1999. Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression. Biol Psychiatry 46:1275-1286.